5
www.mastersheadneckcourse.com Controversies in the Management of Head and Neck and Thyroid cancer 5-6 December 2013 Royal College of Physicians, London, UK. Institute of Head and Neck Studies and Education (INHANSE) in collaboration with Current Concepts in Head and Neck Surgery Endorsed by: MSKCC University of Toronto MDACC ENTUK BAHNO NOTO special focus on the management of recurrent and uncommon head and neck cancers

in collaboration with Current Concepts in Head and …...1 HEAD & NECK ONCOLOGY .com Controversies in the Management of Head and Neck and Thyroid cancer 5-6 December 2013 Royal College

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

1

HEAD & NECK ONCOLOGY

ww

w.m

aste

rshe

ad

ne

ck

co

urse.c

om

Controversies in the

Management of Head and Neck

and Thyroid cancer

5-6 December 2013

Royal College of Physicians, London, UK.

Institute of Head and Neck Studies and Education (INHANSE)

in collaboration with Current Concepts in Head and Neck Surgery

Endorsed by:

MSKCC University of Toronto MDACC

ENTUK BAHNO NOTO

special focus on the management of recurrent and uncommon head and neck cancers

2

Visiting Professors:

The meeting aims to provide delegates with;

Up-to-date, evidence-based protocols for the management of difficult and

controversial areas in Head and Neck and Thyroid cancer; with a special

focus on the management of recurrent and uncommon HNC cancers.

Multidisciplinary discussion forum for the management of common and

more challenging presentations of Head and Neck and Thyroid Cancer.

Compare and contrast US and European treatment protocols and provide

a forum for learning from the two approaches.

Objectives:

ww

w.m

aste

rshe

ad

ne

ck

co

urse.c

om

Suitable for:

Any team member of the multidisciplinary team treating Head and Neck, and Thyroid cancers including:

Clinical and Medical Oncologists

Surgeons

Radiologists

Palliative specialists

Senior Trainees

Clinical Nurse specialists

Speech and Language therapists

Pathologists

Dieticians

Ralph Gilbert

Vincent Grégoire

Patrick Gullane

Ehab Hanna

Lisa Licitra

Alexander D Rapidis

Jatin Shah

Ashok Shaha

Randal Weber

ABOUT THE MEETING

Organising committee:

Course Director: Prof Hisham Mehanna

InHANSE Birmingham: Mr Paul Pracy, Mr Sat Parmar, Mr Tim Martin,

Mr Chris Jennings, Mr John Watkinson and Mr Prav Praveen

BAHNO: Mr Ricard Simo and Mr Nicholas Roland

ENT-UK: Mr Vinidh Paleri

3

ww

w.m

aste

rshe

ad

ne

ck

co

urse

.c

om

Thursday 5th

December

09.00 Registration: Wolfson Foyer

09.45 Advances in the reconstruction of maxillary and mandibular tumours

Parmar

10.05 Breaking news to HPV positive patients

Wilkinson

10.25 Mid morning break: Osler/Long room

10.45 Patient selection for adjuvant treatments in salivary gland tumours

Gregoire

11.05 Latest evidence on the management of sarcoma in head and neck cancer

Harrington

11.25 Update on the management of mucosal melanoma

Kelly

11.45 Multi-disciplinary Tumour board: Salivary tumour, sinonasal and rare tumours

Moderator: Hanna

Ahmed, Martin, McGurk, Gregoire, Harrington, Rapidis, Roland, Weber

Cases include: medium sized, low grade salivary tumour; high grade tumour N0 salivary cancer with encased but functioning nerve; large ethmoidal tumour with involvement of cribriform plate; maxillary tumour with involvement of orbit; sarcoma of the maxilla and ethmoids with orbital involvement; nasal melanoma, oral melanosis of mouth, T4N0 maxillary (hard palate) tumour.

13.30 Lunch: Osler/Long room

Beasley—Surgeon data DAHNO update

14.15 Multi-disciplinary Tumour board: Oral and oropharyngeal cancer

Moderator: Gilbert

Kerwala, Licitra, McCaul, Praveen, Sanghera, Sen, Shaha

Cases include: T1N0 oral cancer; T2N0 oropharyngeal cancer; T1N1 oropharyngeal

cancer; T3N2c oropharyngeal cancer; T4N1 oral cancer.

15.45 Patient selection in the management of early thyroid cancer papillary thyroid

microcarcinoma.

Shaha

16.05 Nuances of the surgical management of gross local invasion in thyroid cancer.

Shah

16.25 Advances in the systemic and radiotherapeutic management of persistent and

metastatic thyroid cancer.

Moss

16.45 Afternoon break: Osler/Long room

17.00 Multi-disciplinary Thyroid Tumour Board

Moderator: Shah

Mehanna, Moss, Newbold, Shaha, Simo, Watkinson

Micropapillary carcinoma (incidental), T2N1 papillary carcinoma, high thyro- globulinaemia, microscopic extracapsular spread, tumour on functioning nerve, medullary carcinoma on hemi-thyroidectomy, high calcitoninaemia

Programme

4

Friday 6th

December

08.00 Arrival: Wolfson Foyer

08.30 Options for the management of T1 – T3 laryngeal cancer

Hanna

08.50 Hypopharyneal cancer – chemoradiotherapy or surgery, the debate continues.

Gullane

09.10 Practical interventions for improving swallowing outcomes following surgical

and non surgical treatment of head and neck cancer.

Reid

09.30 Treatment selection at the extremes of age (adolescents and the elderly)

Speaker to be confirmed

09.50 Multi-disciplinary Tumour board – Laryngeal cancer

Moderator: Gullane

Beasley, Gilbert, Hanna, Hartley, Jennings, Jones. Licitra, Paleri, Pracy

Cases include: T1b laryngeal cancer; small volume T3 laryngeal cancer; T4 laryngeal cancer with minimal cartilage invasion; patient with difficulty swallowing following laryngectomy; patient with difficulty swallowing following chemoradiotherapy; T2 hypopharyngeal cancer.

11.15 Mid morning break: Osler/Long room

11.35 Oropharyngeal cancer recurrence – when and how to treat

Weber

11.55 Indications for chemo re-irradiation in recurrent head and neck cancer

Gregoire

12.15 Decreasing complications of salvage surgery following CRT recurrence

Mehanna

12.35 Lunch: Osler/Long room

13.15 Paradigms for the selection of reconstructive techniques in the management of

recurrence

Gilbert

13.35 Advances in the treatment of pulmonary metastasis and the second primary in

the lung

Forster/Licitra

13.55 Advances in the palliation of recurrent head and neck cancer

Forster/Licitra

14.15 Multi-disciplinary Tumour board – Management of recurrence

Moderator: Weber

Gregoire, Gullane, Homer, Licitra, Mehanna, Nutting, Shah

Cases include: recurrent laryngeal tumour T2; recurrent laryngeal tumour T4; stomal recurrence; oropharyngeal recurrence; patient with single pulmonary nodule following treatment for chemoradiotherapy; patients with recurrent head and neck cancer and pain; hypopharyngeal recurrence requiring reconstruction with poor skin; patient with no recurrence and severe aspiration and no swallow.

16.10 Closing remarks

Afternoon break: Osler/Long room

ww

w.m

aste

rshe

ad

ne

ck

co

urse

.c

om

5

Address:

Royal College of Physicians

11 St Andrews Place

Regent's Park

London. NW1 4LE

REGISTRATION AND FEES

The Royal College of Physicians is located next to

Regent's Park in the centre of London.

For more on directions:

http://www.rcplondon.ac.uk/visit-us

This meeting will take place in the Wolfson Theatre

at the Royal College of Physicians .

2 Days 1 Days

Full delegate £380 £250

Trainees £350 £225

AHPs £250 £150

Fees include lunch, coffees and teas.

EARLY BIRD REGISTRATION

15th September 2013

14 CPD points applied for

10% Discount available for early bird registrations before the 15th of September 2013.

For registration: visit: www.mastersheadneckcourse.com

For further enquiries contact: [email protected]

ww

w.m

aste

rshe

ad

ne

ck

co

urse.c

om

Several hotels are available in the vicinity of the venue at special rates.

Please see: http://www.rcpevents.co.uk/hotels

Accommodation:

VENUE AND ACCOMMODATION

deadline